Literature DB >> 18667929

Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study.

Christian Mouala1, Sandrine Houzé, Marguerite Guiguet, Philippe Abboud, Gilles Pialoux, Nathalie Viget, Dominique Costagliola, Sophie Matheron.   

Abstract

BACKGROUND: To describe episodes of imported malaria in human immunodeficiency virus type 1-infected patients and to study the risk factors for severe Plasmodium falciparum malaria.
METHODS: Patients enrolled in the French Hospital Database on HIV who were diagnosed with a first episode of malaria between 1996 and 2003 were included. The severity of P. falciparum imported malaria was graded with World Health Organization criteria. Geographic areas were classified according to P. falciparum chemoresistance. Risk factors for severe malaria were identified with logistic regression.
RESULTS: We studied 190 patients infected by P. falciparum in 178 cases. All but four of the patients were infected in sub-Saharan Africa, and half were returning from a country with a high P. falciparum chloroquine resistance. Their median age was 37.5 years, and 57% came from a country endemic with malaria. The median CD4 cell count was 299/mm, and the median plasma human immunodeficiency virus type 1 RNA load was 4.5 log10 copies/mL. Sixty-five (36.5%) episodes of P. falciparum malaria were severe. Severe imported malaria was associated with CD4 cells/mm <350 (odds ratio = 2.58; 95% confidence interval: 1.19 to 5.57). The risk of severe malaria was lower in patients returning from a country with a high prevalence of chemoresistance (odds ratio = 0.50; 95% confidence interval: 0.25 to 0.99).
CONCLUSIONS: Severe imported malaria in human immunodeficiency virus type 1-infected patients is associated with decreased CD4 cell count. The risk seems lower when P. falciparum infection was acquired in areas of high prevalence of chemoresistance.

Entities:  

Mesh:

Year:  2008        PMID: 18667929     DOI: 10.1097/QAI.0b013e31817e635b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

1.  Antimalaria action of antiretroviral drugs on Plasmodium berghei in mice.

Authors:  Akinwumi Akinyede; Alade Akintonwa; Olufunsho Awodele; Sunday Olayemi; Ibrahim Oreagba; Charles Okany; Oluwagbemiga Aina; Samuel Akindele
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

2.  Malaria and hiv in adults: when the parasite runs into the virus.

Authors:  Emanuele Focà; Silvia Odolini; Nigritella Brianese; Giampiero Carosi
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-07       Impact factor: 2.576

3.  The Effect of Malaria and HIV Co-Infection on Anemia: A Meta-Analysis.

Authors:  Cho Naing; Nisha Kaur Sandhu; Victor Nyunt Wai
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Effect of malaria and HIV/AIDS co-infection on red blood cell indices and its relation with the CD4 level of patients on HAART in Bench Sheko Zone, Southwest Ethiopia.

Authors:  Solomon Ejigu; Diresbachew Haile; Yerukneh Solomon
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

5.  Plasmodium knowlesi and HIV co-infection in a German traveller to Thailand.

Authors:  Jonas Ehrhardt; Andreas Trein; Peter Kremsner; Matthias Frank
Journal:  Malar J       Date:  2013-08-13       Impact factor: 2.979

6.  Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.

Authors:  Laure-Amélie de Monteynard; Sophie Matheron; Sophie Grabar; Pierre de Truchis; Jacques Gilquin; Juliette Pavie; Odile Launay; Jean-Luc Meynard; Marie-Aude Khuong-Josses; David Rey; Aba Mahamat; Rosemarie Dray-Spira; Anne Simon; Dominique Costagliola; Sophie Abgrall
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.